99 related articles for article (PubMed ID: 20006981)
1. Regulation of VDR expression in rat and human intestine and liver--consequences for CYP3A expression.
Khan AA; Dragt BS; Porte RJ; Groothuis GM
Toxicol In Vitro; 2010 Apr; 24(3):822-9. PubMed ID: 20006981
[TBL] [Abstract][Full Text] [Related]
2. Comparison of effects of VDR versus PXR, FXR and GR ligands on the regulation of CYP3A isozymes in rat and human intestine and liver.
Khan AA; Chow EC; van Loenen-Weemaes AM; Porte RJ; Pang KS; Groothuis GM
Eur J Pharm Sci; 2009 May; 37(2):115-25. PubMed ID: 19429418
[TBL] [Abstract][Full Text] [Related]
3. Expression and regulation of the bile acid transporter, OSTalpha-OSTbeta in rat and human intestine and liver.
Khan AA; Chow EC; Porte RJ; Pang KS; Groothuis GM
Biopharm Drug Dispos; 2009 Jul; 30(5):241-58. PubMed ID: 19562681
[TBL] [Abstract][Full Text] [Related]
4. The role of lithocholic acid in the regulation of bile acid detoxication, synthesis, and transport proteins in rat and human intestine and liver slices.
Khan AA; Chow EC; Porte RJ; Pang KS; Groothuis GM
Toxicol In Vitro; 2011 Feb; 25(1):80-90. PubMed ID: 20888898
[TBL] [Abstract][Full Text] [Related]
5. 1alpha,25-Dihydroxyvitamin D(3) triggered vitamin D receptor and farnesoid X receptor-like effects in rat intestine and liver in vivo.
Chow EC; Maeng HJ; Liu S; Khan AA; Groothuis GM; Pang KS
Biopharm Drug Dispos; 2009 Nov; 30(8):457-75. PubMed ID: 19753549
[TBL] [Abstract][Full Text] [Related]
6. Role of vitamin D receptor in the lithocholic acid-mediated CYP3A induction in vitro and in vivo.
Matsubara T; Yoshinari K; Aoyama K; Sugawara M; Sekiya Y; Nagata K; Yamazoe Y
Drug Metab Dispos; 2008 Oct; 36(10):2058-63. PubMed ID: 18645036
[TBL] [Abstract][Full Text] [Related]
7. Comparative effects of 1α-hydroxyvitamin D3 and 1,25-dihydroxyvitamin D3 on transporters and enzymes in fxr(+/+) and fxr(-/-) mice.
Chow EC; Durk MR; Maeng HJ; Pang KS
Biopharm Drug Dispos; 2013 Oct; 34(7):402-16. PubMed ID: 23897575
[TBL] [Abstract][Full Text] [Related]
8. Selective induction of intestinal CYP3A23 by 1alpha,25-dihydroxyvitamin D3 in rats.
Xu Y; Iwanaga K; Zhou C; Cheesman MJ; Farin F; Thummel KE
Biochem Pharmacol; 2006 Jul; 72(3):385-92. PubMed ID: 16769037
[TBL] [Abstract][Full Text] [Related]
9. Lithocholic Acid Is a Vitamin D Receptor Ligand That Acts Preferentially in the Ileum.
Ishizawa M; Akagi D; Makishima M
Int J Mol Sci; 2018 Jul; 19(7):. PubMed ID: 29986424
[TBL] [Abstract][Full Text] [Related]
10. Effects of 1alpha,25-dihydroxyvitamin D3 on transporters and enzymes of the rat intestine and kidney in vivo.
Chow EC; Sun H; Khan AA; Groothuis GM; Pang KS
Biopharm Drug Dispos; 2010 Jan; 31(1):91-108. PubMed ID: 20013813
[TBL] [Abstract][Full Text] [Related]
11. Alteration of cellular phosphorylation state affects vitamin D receptor-mediated CYP3A4 mRNA induction in Caco-2 cells.
Hara H; Yasunami Y; Adachi T
Biochem Biophys Res Commun; 2002 Aug; 296(1):182-8. PubMed ID: 12147248
[TBL] [Abstract][Full Text] [Related]
12. Vitamin D receptor as an intestinal bile acid sensor.
Makishima M; Lu TT; Xie W; Whitfield GK; Domoto H; Evans RM; Haussler MR; Mangelsdorf DJ
Science; 2002 May; 296(5571):1313-6. PubMed ID: 12016314
[TBL] [Abstract][Full Text] [Related]
13. Involvement of Vitamin D receptor in the intestinal induction of human ABCB1.
Tachibana S; Yoshinari K; Chikada T; Toriyabe T; Nagata K; Yamazoe Y
Drug Metab Dispos; 2009 Aug; 37(8):1604-10. PubMed ID: 19460946
[TBL] [Abstract][Full Text] [Related]
14. Lithocholic acid can carry out in vivo functions of vitamin D.
Nehring JA; Zierold C; DeLuca HF
Proc Natl Acad Sci U S A; 2007 Jun; 104(24):10006-9. PubMed ID: 17535892
[TBL] [Abstract][Full Text] [Related]
15. Modulation of bile acid metabolism by 1alpha-hydroxyvitamin D3 administration in mice.
Nishida S; Ozeki J; Makishima M
Drug Metab Dispos; 2009 Oct; 37(10):2037-44. PubMed ID: 19581390
[TBL] [Abstract][Full Text] [Related]
16. Intestinal CYP3A4 protects against lithocholic acid-induced hepatotoxicity in intestine-specific VDR-deficient mice.
Cheng J; Fang ZZ; Kim JH; Krausz KW; Tanaka N; Chiang JY; Gonzalez FJ
J Lipid Res; 2014 Mar; 55(3):455-65. PubMed ID: 24343899
[TBL] [Abstract][Full Text] [Related]
17. 1,25-Dihydroxyvitamin D3 up-regulates the renal vitamin D receptor through indirect gene activation and receptor stabilization.
Healy KD; Frahm MA; DeLuca HF
Arch Biochem Biophys; 2005 Jan; 433(2):466-73. PubMed ID: 15581603
[TBL] [Abstract][Full Text] [Related]
18. Beneficial effect of farnesoid X receptor activation on metabolism in a diabetic rat model.
Zhang HM; Wang X; Wu ZH; Liu HL; Chen W; Zhang ZZ; Chen D; Zeng TS
Mol Med Rep; 2016 Mar; 13(3):2135-42. PubMed ID: 26782298
[TBL] [Abstract][Full Text] [Related]
19. Differential activation of the human farnesoid X receptor depends on the pattern of expressed isoforms and the bile acid pool composition.
Vaquero J; Monte MJ; Dominguez M; Muntané J; Marin JJ
Biochem Pharmacol; 2013 Oct; 86(7):926-39. PubMed ID: 23928191
[TBL] [Abstract][Full Text] [Related]
20. Regulation of gene expression of epithelial calcium channels in intestine and kidney of mice by 1alpha,25-dihydroxyvitamin D3.
Okano T; Tsugawa N; Morishita A; Kato S
J Steroid Biochem Mol Biol; 2004 May; 89-90(1-5):335-8. PubMed ID: 15225796
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]